Breakout Stocks – Corona Virus Stocks It would not be a surprise if BioNTech ($BNTX) hits a promising share price in the coming weeks. The company crashed on Tuesday with a small discount at a high level and according to various analysts should still make a run for a maximum price target. If the perspective…
While major international pharmaceutical companies from the Western world are fully committed to producing an FDA and EUA-approved vaccine, there are competitors in other parts of the world looking to provide our planet with a vaccine more quickly than initially thought. What does this mean for pharmaceutical like AstraZeneca ($AZN), Moderna ($MRNA) and Pfizer ($PFE)…
Roche ($RHHBY) launched its Elecsys Anti-SARS-CoV-2 S antibody test for markets that accept the CE mark. It has also filed with the Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA). The test can be used to measure antibodies in people exposed to COVID-19. The company believes the test can play an important…
Just before the 59th US presidential election, President Donald Trump is much discussed by the media. It seems this is a time when people are either really pro- or against the president. Various reports mentioning the American president can have an significant impact on the stock market, which is why PSN highlighted the press releases…
EyePoint Pharmaceuticals, Inc. ($EYPT) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. Recent developments equals happy investors? A little month ago, its share rose with 35% on the premarket after expanding its…
For months the world has been under the spell of the COVID-19 vaccine race, as society is very anxious to see which pharmaceutical company will be the first to complete its Phase 3 study. A live tracker has been published on the website of The New York Times to see which pharmaceuticals are in which…
XpresSpa Group ($XSPA) is the world’s largest provider of airport spa facilities and had to come up with a new market strategy as the coronavirus ravages the world. Where the share steadily increased at the beginning of this year, soon after the spread of the virus it became clear that the company had to change…
This morning pharmaceutical and medicine giant AstraZeneca ($AZN) announced an immediate interruption of the COVID-19 vaccine test during the Phase 3 study, after a participant in from the UK showed severe neurological symptoms of an unexplained disease. As a result, the company has discontinued the standard process in order to review the safety data first.…
Novavax, Inc. ($NVAX) has been one of the biggest pioneers on the pharmaceutical market since the outbreak of the COVID-19 pandemic. This is mainly due to the extreme increase that the NVAX share has seen this year, by growing with a sensational 2000%. As several biotech companies have begun phase 3 clinical trials for an…
Vaxart, Inc. ($VXRT) – a well-known clinical stage biotechnology company developing oral recombinant vaccines that are administered via tablets rather than injections – is breaking the news this morning. The COVID-19 vaccine candidate has shown encouraging results in preclinical research. Vaxart is now announcing a pre-publication of a manuscript on this matter named: “Preclinical Studies…
